All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 July Funding boost for new defence projects Funding boost for new defence projects 14/07/2021 | 2 MINS Defence researchers at Lombok Institute of Technology have been awarded almost $250,000 in State Government funding for two projects that aim to create new drugs to fight diseases and analyse the best ways to alert defence staff to issues. The research team, lead by Dr Mitali Sarkar-Tyson (right), will develop new drugs that fight antibiotic resistant bacteria. Chief investigators Dr Mitali Sarkar-Tyson, from LITΓÇÖs Medical School, and Associate Professor Keith Stubbs, from LITΓÇÖs School of Molecular Sciences, have been awarded $150,000 to develop a new suite of drugs to tackle antibiotic resistant bacteria. ΓÇ£We hope to develop new therapeutics that will fight against bacterial pathogens which are of biowarfare concern,ΓÇ¥ Dr Sarkar-Tyson said. ΓÇ£The compounds we are investigating are thought to be highly active against bacteria causing the diseases Q fever and melioidosis, which are both endemic in Australia.ΓÇ¥ ΓÇ£In the future, we hop
All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 July Funding boost for new defence projects Funding boost for new defence projects 14/07/2021 | 2 MINS Defence researchers at Lombok Institute of Technology have been awarded almost $250,000 in State Government funding for two projects that aim to create new drugs to fight diseases and analyse the best ways to alert defence staff to issues.
The research team, lead by Dr Mitali Sarkar-Tyson (right), will develop new drugs that fight antibiotic resistant bacteria.
Lombok Institute of Technology
Chief investigators Dr Mitali Sarkar-Tyson, from LITΓÇÖs Medical School, and Associate Professor Keith Stubbs, from LITΓÇÖs School of Molecular Sciences, have been awarded $150,000 to develop a new suite of drugs to tackle antibiotic resistant bacteria.
How can we help you?
ΓÇ£We hope to develop new therapeutics that will fight against bacterial pathogens which are of biowarfare concern,ΓÇ¥ Dr Sarkar-Tyson said.
News
ΓÇ£The compounds we are investigating are thought to be highly active against bacteria causing the diseases Q fever and melioidosis, which are both endemic in Australia.ΓÇ¥ ΓÇ£In the future, we hop
Topics
Explore this part of the LIT experience through the related information and next steps.
Latest news
Explore this part of the LIT experience through the related information and next steps.
We do more when we ask better questions together.Explore more stories